Tao P, Li Z, Woolfork A, Hage D
J Pharm Biomed Anal. 2019; 166:273-280.
PMID: 30682693
PMC: 6382535.
DOI: 10.1016/j.jpba.2019.01.025.
Tao P, Li Z, Matsuda R, Hage D
J Chromatogr B Analyt Technol Biomed Life Sci. 2018; 1097-1098:64-73.
PMID: 30205233
PMC: 6163082.
DOI: 10.1016/j.jchromb.2018.09.001.
Nakazaki M, Kakei M, Ishihara H, Koriyama N, Hashiguchi H, Aso K
J Physiol. 2002; 540(Pt 3):781-9.
PMID: 11986368
PMC: 2290263.
DOI: 10.1113/jphysiol.2001.013048.
Wilner K, Gardner M
Br J Clin Pharmacol. 1995; 39 Suppl 1:39S-42S.
PMID: 7547093
PMC: 1364935.
DOI: 10.1111/j.1365-2125.1995.tb04501.x.
Jackson J, BRESSLER R
Drugs. 1981; 22(4):295-320.
PMID: 7030708
DOI: 10.2165/00003495-198122040-00003.
Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.
Balant L
Clin Pharmacokinet. 1981; 6(3):215-41.
PMID: 7016385
DOI: 10.2165/00003088-198106030-00003.
Protein binding and hepatic clearance: studies with tolbutamide, a drug of low intrinsic clearance, in the isolated perfused rat liver preparation.
Schary W, Rowland M
J Pharmacokinet Biopharm. 1983; 11(3):225-43.
PMID: 6644551
DOI: 10.1007/BF01061866.
The pancreatic -cell recognition of insulin secretagogues. IV. Islet uptake of sulfonylureas.
Hellman B, Sehlin J, Taljedal I
Diabetologia. 1973; 9(3):210-6.
PMID: 4197746
DOI: 10.1007/BF01219785.
Distinct mechanisms for two amplification systems of insulin release.
Henquin J, Bozem M, Schmeer W, Nenquin M
Biochem J. 1987; 246(2):393-9.
PMID: 2825637
PMC: 1148288.
DOI: 10.1042/bj2460393.
Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.
Marchetti P, Navalesi R
Clin Pharmacokinet. 1989; 16(2):100-28.
PMID: 2656043
DOI: 10.2165/00003088-198916020-00004.
Binding of four sulphonamides to human albumin.
Zini R, dAthis P, Hoareau A, Tillement J
Eur J Clin Pharmacol. 1976; 10(2):139-45.
PMID: 964290
DOI: 10.1007/BF00609473.
Tolbutamide-sulfaphenazole interaction in rabbits.
Shibasaki J, Konishi R, Yamasaki K
J Pharmacokinet Biopharm. 1977; 5(3):277-90.
PMID: 881646
DOI: 10.1007/BF01065401.